SARS-CoV-2 Spike / Unconjugated /
Product Details
| Description | A coronavirus, SARS-CoV-2 was first identified in 2019 (COVID-19). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS-CoV-2 can be mediated by the binding of the viral spike protein, a glycosylated protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. | |
|---|---|---|
| Conjugate | Unconjugated | |
| Clone | ||
| Target Species | Virus | |
| Applications | ELISA, IF, WB | |
| Supplier | Leinco | |
| Catalog # | Sign in to view product details, citations, and spectra | |
| Size | ||
| Price | ||
| Antigen | ||
| Host | ||
| Isotype |
Experiment Design Tools
Panel Builders
Looking to design a Microscopy or Flow Cytometry experiment?
Validation References
| Additional Sources |
|
|---|
Reviews & Ratings
| Reviews |
|---|
Looking for more options?
408 SARS-CoV-2 Spike antibodies from over 5 suppliers available with over 25 conjugates.
